Literature DB >> 13641186

Hematogenous pyelonephritis in rats. III. Relationship of bacterial species to the pathogenesis of acute pyeionephritis.

A I BRAUDE, A P SHAPIRO, J SIEMIENSKI.   

Abstract

Entities:  

Keywords:  PYELONEPHRITIS/experimental

Mesh：

Year:  1959        PMID： 13641186      PMCID： PMC290365          DOI： 10.1128/jb.77.3.270-280.1959

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  7 in total

1.  Studies in urolithiasis. III. Physicochemical principles in stone formation and prevention.

Authors:  E L PRIEN
Journal:  J Urol       Date:  1955-04       Impact factor: 7.450

2.  An illustrative case of chronic pyelonephritis with persistently hypotonic urine.

Authors:  C R KLEEMAN; F H EPSTEIN
Journal:  Am J Med       Date:  1957-09       Impact factor: 4.965

3.  Hematogenous pyelonephritis in rats. I. Its pathogenesis when produced by a simple new method.

Authors:  A I BRAUDE; A P SHAPIRO; J SIEMIENSKI
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808

4.  Observations on the pathogenesis, course and treatment of nonobstructive pyelonephritis.

Authors:  H D BRAINERD; L M CECIL
Journal:  Ann Intern Med       Date:  1956-08       Impact factor: 25.391

5.  Hematogenous pyelonephritis in rats. II. Production of chronic pyelonephritis by Escherichia coli.

Authors:  A P SHAPIRO; A I BRAUDE; J SIEMIENSKI
Journal:  Proc Soc Exp Biol Med       Date:  1956-01

6.  Factors in the pathogenesis of pyelonephritis.

Authors:  P B BEESON
Journal:  Yale J Biol Med       Date:  1955-11

7.  Experimental pyelonephritis. I. Effect of ureteral ligation on the course of bacterial infection in the kidney of the rat.

Authors:  P B BEESON; L B GUZE
Journal:  J Exp Med       Date:  1956-12-01       Impact factor: 14.307
  7 in total
  9 in total

1.  Increased susceptibility to pyelonephritis during acute hypertension by angiotensin II and norepinephrine.

Authors:  R K JONES; A P SHAPIRO
Journal:  J Clin Invest       Date:  1963-02       Impact factor: 14.808

2.  Role of bacterial urease in experimental pyelonephritis.

Authors:  A I BRAUDE; J SIEMIENSKI
Journal:  J Bacteriol       Date:  1960-08       Impact factor: 3.490

3.  Preparation and biological properties of a chemically modified Escherichia coli endotoxin of high immunogenic potency and low toxicity.

Authors:  H NOLL; A I BRAUDE
Journal:  J Clin Invest       Date:  1961-11       Impact factor: 14.808

4.  The influence of bacteriocins on resistance to infection by gram-negative bacteria. II. Colicin action, transfer of colicinogeny, and transfer of antibiotic resistance in urinary infections.

Authors:  A I Braude; J S Siemienski
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

5.  Hematogenous pyelonephritis in rats. IV. Relationship of bacterial species to the pathogenesis and sequelae of chronic pyelonephritis.

Authors:  A P SHAPIRO; A I BRAUDE; J SIEMIENSKI
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

6.  Urea utilization by Leptospira.

Authors:  S Kadis; W L Pugh
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

7.  Rat pyelonephritis model suitable for primary or secondary screening.

Authors:  S E Burrous; J B Cawein
Journal:  Appl Microbiol       Date:  1969-09

8.  An experimental model for ascending acute pyelonephritis caused by Escherichia coli or proteus in rats.

Authors:  P Larsson; B Kaijser; I M Baltzer; S Olling
Journal:  J Clin Pathol       Date:  1980-04       Impact factor: 3.411

9.  Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.

Authors:  D E Johnson; R G Russell; C V Lockatell; J C Zulty; J W Warren; H L Mobley
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.